ARA-290 8mg
€51.00
ARA-290 Peptide (8mg) is a synthetic erythropoietin (EPO) derivative studied for its potential in tissue repair, metabolic regulation, and neuropathic pain relief. Research suggests applications in small fiber neuropathy and anti-inflammatory processes.
✓ Fast delivery
✓ Premium quality
✓ 3th party tested
In Stock
CompareDescription
ARA-290 Peptide (8mg)
Molecular Information
- Molecular formula: C51H84N16O21
- Molecular weight: 1257.3 g/mol
- PubChem CID: 91810664
- Synonyms: Cibinetide, ARA290, 1208243-50-8, PHBSP, PH-BSP
Research Applications
- Tissue Repair
- Metabolic Regulation
- Neuropathic Pain Relief
- Small Fiber Neuropathy
What is ARA-290?
ARA-290 is a synthetic peptide developed as an erythropoietin (EPO) derivative, designed to selectively bind to the innate repair receptor (IRR). Unlike EPO, ARA-290 does not exhibit erythropoietic activity but instead promotes tissue protection, anti-inflammatory responses, and pain modulation. Research on ARA-290 has focused on its ability to repair damaged tissues, regulate metabolic function, and improve nerve-related conditions such as neuropathic pain and small fiber neuropathy.
ARA-290 and Tissue Repair
ARA-290 interacts with the innate repair receptor to modulate inflammation and support tissue regeneration. Studies suggest that it reduces oxidative stress and cellular damage while enhancing wound healing in preclinical models. Due to its potential regenerative properties, ARA-290 has been researched for applications in injury recovery and chronic inflammatory conditions.
ARA-290 and Metabolic Regulation
ARA-290 has been studied for its role in improving metabolic parameters, particularly in individuals with type 2 diabetes. Research suggests that this peptide may reduce HbA1c levels, improve insulin sensitivity, and enhance lipid metabolism. These findings indicate that ARA-290 could be beneficial in metabolic disease research, particularly in conditions related to glucose regulation and lipid disorders.
ARA-290 and Neuropathic Pain Relief
Studies have shown that ARA-290 may be effective in alleviating neuropathic pain, particularly in chronic conditions like sarcoidosis-associated pain. By interacting with the innate repair receptor, ARA-290 helps regulate inflammatory pathways and neuronal repair processes, providing pain relief without the side effects commonly associated with traditional pain medications.
ARA-290 and Small Fiber Neuropathy
Small fiber neuropathy (SFN) is a condition characterized by nerve damage leading to pain and sensory impairment. Clinical studies indicate that ARA-290 treatment has resulted in increased corneal nerve fiber density and significant symptom improvement in SFN patients. These findings suggest that ARA-290 may offer a potential disease-modifying approach for neuropathic disorders.
Legal Disclaimer
This product is sold as a pure compound for research purposes only and is not intended for use as a dietary supplement. Please review our terms and conditions before purchasing.
Safety Information
Keep this product out of the reach of children. Research on ARA-290 is ongoing, and improper handling may result in unintended effects. This product is for laboratory research only and is not for human or veterinary use.
We ensure the highest standards for product quality and description but are not responsible for improper handling or application.
The information provided is for educational and informational purposes only. This compound has not been evaluated by the FDA and is not intended to diagnose, prevent, or treat any medical condition.
